Tarsus Pharmaceuticals Inc (TARS)

Other Income/Expenses (Net)

$4.07M

Quarterly · Period ending: · USD

TARS logo

TARS Other Income/Expenses (Net)

Latest reported$4.07M
TARS Quarterly Other Income/Expenses (Net) ($8.00K → $4.07M)
High-resolution chart · PNG

TARS other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tarsus Pharmaceuticals Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
4,073,000
-3,197,000
1,662,000
1,944,000
1,844,000
1,160,000
1,308,000
1,742,000
12,000
1,953,000
2,548,000
1,787,000
1,397,000
1,533,000
1,462,000
390,000
-519,000
-716,000
-349,000
-333,000
-908,000
-25,000
10,000
4,000
13,000
161,000
-328,000
-48,000
8,000
8,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.